A toll-like receptor agonist to drive melanoma regression as a vaccination adjuvant or by direct tumor application.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Richard Eldon Royal, Luis M Vence, Tara Wray, Janice N. Cormier, Jeffrey Edwin Lee, Jeffrey E. Gershenwald, Merrick I. Ross, Jennifer Ann Wargo, Rodabe Navroze Amaria, Michael A. Davies, Adi Diab, Isabella Claudia Glitza, Wen-Jen Hwu, Sapna Pradyuman Patel, Scott Eric Woodman, Willem W Overwijk, Patrick Hwu
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2892325563